The first-of-its-kind pilot could lead to speedier regulatory approval of medical drugs and devices and potentially reduce ...
TISSIUM, a Medical Technology company pioneering biomorphic programmable polymers for tissue reconstruction, announced today it has appointed Marc Quartulli as its Vice President of Clinical Affairs.
As climate change accelerates and global temperatures continue to rise, a new randomized clinical trial provides compelling ...
AI's performance in diagnostic tasks exceeds that of physicians, indicating a shift towards integrating advanced models in ...
The US Food and Drug Administration (FDA) has announced plans for a future pilot program intended to facilitate the real-time ...
New BPEI preclinical data address treatment protocol, corneal biochemical environment, fungal resistance mechanism, MRSA biofilm inhibition, and ...
An FDA initiative to implement real-time clinical trials could dramatically accelerate the pace at which new treatments ...
Dr. Marty Makary, the FDA’s commissioner, said the program targets “dead time,” or about half the time between the launch of ...
Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But ...
Clinical-stage biotech is one of the few corners of the market where a sub-$30 share price genuinely matters: small-cap ...
Individuals that share the same deletion of a portion of chromosome 16 are at risk of developing neurodevelopmental disorders ...
With documentation burden one of the real and unglamorous drivers of burnout in the veterinary profession, veterinarian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results